Ontology highlight
ABSTRACT: Aims
To assess the pharmacokinetic (PK) profile of, and users' reactions to, Juul (59 mg nicotine/ml) as an indication of its therapeutic and dependence potential.Design
Cross-over, within-subjects study in which participants attended after overnight abstinence on separate sessions and smoked a cigarette or used Juul or eight other types of e-cigarettes (EC) ad libitum for 5 minutes. The Juul product used was the version available in the United States that has more nicotine in the e-liquid than the one available in the European Union.Setting
Laboratory setting in the United Kingdom.Participants
Twenty dual users (smokers who also vape) provided data on Juul and cigarettes, with eight also providing data on other EC products.Measurements
At each sessi
SUBMITTER: Hajek P
PROVIDER: S-EPMC7318270 | biostudies-literature | 2020 Jun
REPOSITORIES: biostudies-literature